NZ277238A - Taste masked composition containing paroxetine complexed with a polymer - Google Patents

Taste masked composition containing paroxetine complexed with a polymer

Info

Publication number
NZ277238A
NZ277238A NZ277238A NZ27723894A NZ277238A NZ 277238 A NZ277238 A NZ 277238A NZ 277238 A NZ277238 A NZ 277238A NZ 27723894 A NZ27723894 A NZ 27723894A NZ 277238 A NZ277238 A NZ 277238A
Authority
NZ
New Zealand
Prior art keywords
polymer
chewable
taste masked
therapeutic agent
paroxetine
Prior art date
Application number
NZ277238A
Other languages
English (en)
Inventor
Franco Francese
Massimo Maneschi
Diego Oldani
Tiziana Crolla
Original Assignee
Smithkline Beecham Spa Formerl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Spa Formerl filed Critical Smithkline Beecham Spa Formerl
Publication of NZ277238A publication Critical patent/NZ277238A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ277238A 1993-12-03 1994-11-24 Taste masked composition containing paroxetine complexed with a polymer NZ277238A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
PCT/EP1994/003903 WO1995015155A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex

Publications (1)

Publication Number Publication Date
NZ277238A true NZ277238A (en) 1998-04-27

Family

ID=11367288

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ277238A NZ277238A (en) 1993-12-03 1994-11-24 Taste masked composition containing paroxetine complexed with a polymer

Country Status (9)

Country Link
EP (1) EP0804168A1 (zh)
JP (1) JPH09505818A (zh)
CN (1) CN1145586A (zh)
AU (1) AU693144B2 (zh)
CA (1) CA2177721A1 (zh)
IT (1) IT1274241B (zh)
NZ (1) NZ277238A (zh)
WO (1) WO1995015155A1 (zh)
ZA (1) ZA949567B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
WO1998056787A1 (en) 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
JP4854115B2 (ja) 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
ES2261726T3 (es) * 2001-08-09 2006-11-16 Smithkline Beecham Plc Composicion que comprende paroxetina y una sal glicirricinato farmaceuticamente aceptable.
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
AU2011379627B2 (en) * 2011-10-25 2015-09-10 Expermed S.A. Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79816A (en) * 1985-08-26 1990-11-05 Searle & Co Pharmaceutical compositions comprising a drug-polymer matrix

Also Published As

Publication number Publication date
EP0804168A1 (en) 1997-11-05
CA2177721A1 (en) 1995-06-08
ITMI932540A0 (it) 1993-12-03
AU1219895A (en) 1995-06-19
JPH09505818A (ja) 1997-06-10
ZA949567B (en) 1995-10-10
CN1145586A (zh) 1997-03-19
IT1274241B (it) 1997-07-15
WO1995015155A1 (en) 1995-06-08
ITMI932540A1 (it) 1995-06-03
AU693144B2 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
US4814354A (en) Lipid regulating agents
JP2568202B2 (ja) 制御放出型ジヒドロコデイン組成物
US10441585B2 (en) Formulations containing nalbuphine and uses thereof
KR870001960B1 (ko) 피록시캄 착물의 제조 방법
NZ277238A (en) Taste masked composition containing paroxetine complexed with a polymer
EP0717986B1 (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally, dextromethorphan
EP1370247B1 (en) Taste masked pharmaceutical compositions
TWI398273B (zh) 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
US20070122475A1 (en) Taste masking composition
CA2619438A1 (en) Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino(4,5-b) indole-1-acetamide
CN1994468A (zh) 不良口感药物掩味颗粒、可咀嚼制剂及其制备工艺
JP2002514212A (ja) セフアドロキシル一水和物錠剤処方物
US20110300224A1 (en) Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
US7229980B2 (en) Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or derivative thereof
EP0297866A2 (en) Therapeutic agents
WO1994028936A1 (en) Process for the preparation of an oral solid dosage form containing diclofenac
WO2007086846A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
RU2240784C1 (ru) Лекарственное средство на основе арбидола
US5560921A (en) Chewable decongestant compositions
CA2136946C (en) Oral decongestant product
JP4719899B2 (ja) 口腔内速崩壊性錠剤
HU204997B (en) Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access
JPS62190126A (ja) ジフルニザ−ルとトロメタミンの混合組成物